BindingDB logo
myBDB logout

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
24900877 107 Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.EBI Merck Research Laboratories
19715320 87 Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.EBI University of Florida
14980679 30 Dipeptidyl aspartyl fluoromethylketones as potent caspase-3 inhibitors: SAR of the P2 amino acid.EBI Maxim Pharmaceuticals
18387304 4 Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.EBI Tokyo University of Science
17889532 23 Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P(2) amino acid by 2-aminoaryl acids and other non-natural amino acids.EBI EpiCept Corporation
15713391 19 Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.EBI Maxim Pharmaceuticals
15454214 26 Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group.EBI Maxim Pharmaceuticals
15109679 15 Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.EBI Idun Pharmaceuticals, Inc.
28238723 39 Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors.BDB University of Colorado
11384246 86 Potent and selective nonpeptide inhibitors of caspases 3 and 7.BDB GlaxoSmithKline